Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

NCT00189800 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)

NCT00124306 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects

NCT02821312 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

NCT01318837 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome

NCT02858453 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

NCT02485067 ·Status: COMPLETED ·Phase: PHASE3

MIrabegron With oveRACtive bLadder Symptoms in mEn

NCT02361502 ·Status: UNKNOWN ·Phase: PHASE4

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

NCT01972841 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

NCT01578304 ·Status: COMPLETED ·Phase: PHASE4

InSite for Over Active Bladder

NCT00547378 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder.

NCT06753071 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

NCT00985387 ·Status: COMPLETED

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

NCT04023253 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.

NCT04483817 ·Status: UNKNOWN ·Phase: NA

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

NCT01093534 ·Status: COMPLETED ·Phase: PHASE4

To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

NCT04917315 ·Status: COMPLETED ·Phase: PHASE3

Silodosin vs Placebo in the Treatment of Female LUTS

NCT06114979 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

NCT02468375 ·Status: COMPLETED ·Phase: PHASE4

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3

The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients

NCT02271607 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

NCT00646880 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT01868516 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

NCT01458197 ·Status: COMPLETED ·Phase: PHASE2

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

NCT02045862 ·Status: COMPLETED ·Phase: PHASE3

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

NCT05878951 ·Status: RECRUITING ·Phase: PHASE2/PHASE3